Company Filing History:
Years Active: 2006
Title: Sarah Clough - Innovator in Melanin-Concentrating Hormone Research
Introduction
Sarah Clough is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target melanin-concentrating hormone receptors. Her work has implications for treating disorders related to obesity.
Latest Patents
Sarah Clough holds a patent for "Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto." This patent describes the utility of MCH receptor antagonists for treating MCH receptor-based disorders, such as obesity. The compounds disclosed in her patent include stereoisomers and pharmaceutically acceptable salts, with specific structural definitions provided. Additionally, the patent covers pharmaceutical compositions containing these compounds and methods for their use.
Career Highlights
Sarah Clough is currently associated with Neurocrine Biosciences, Inc., where she continues her research and development efforts. Her innovative work has led to advancements in understanding and treating obesity-related disorders.
Collaborations
Some of her notable coworkers include Val S Goodfellow and Martin W Rowbottom, who have collaborated with her on various projects within the field.
Conclusion
Sarah Clough's contributions to the field of melanin-concentrating hormone research highlight her role as an influential inventor. Her patent and ongoing work at Neurocrine Biosciences, Inc. demonstrate her commitment to advancing medical science and improving treatment options for obesity-related disorders.